Government of Canada invests in national coordination and Indigenous-led research on effective substance use interventions
New research led by UCLA Health has found a drug that treats insomnia works to prevent the addictive effects of the morphine opioids in mice while still providing effective pain relief.
In 2016, nearly 2 million opioid prescriptions were given to patients across the state. However, by the end of the study period in 2020, there was a 38 percent decrease in opioid prescriptions written, according to this study by Dr. Asif Ilyas.
Researchers at Washington University School of Medicine in St. Louis, with collaborators at the University of Florida and Stanford University, identified a compound that, in mice, makes naloxone much more effective at counteracting a drug overdose.
The U.S. Supreme Court has blocked the Sackler family's bid for immunity from opioid-related lawsuits in a landmark decision. This ruling marks a pivotal moment in the ongoing opioid crisis, potentially reshaping how litigation against pharmaceutical companies is handled nationwide.
Christian Hendershot, PhD, associate professor of psychiatry and director of the Clinical and Translational Addiction Research Program at the UNC School of Medicine, presented early findings from the first completed randomized controlled trial of semaglutide for reducing alcohol consumption in heavy drinkers.
New research from the Indiana University Kelley School of Business explains how pharmaceutical companies were able to saturate the country with massive quantities of opioids, despite efforts by the Drug Enforcement Administration to regulate their supply.
Research published in Science Advances traced the history of human’s ability to feel cold back to the molecular underpinnings of the cold and menthol sensor TRPM8 over hundreds of millions of years. The findings could lead to non-addictive pain medications, a crucial development given the opioid crisis.
A rigorous, comprehensive synthesis of evidence from 62 studies related to the use of oral nicotine pouches by Georgetown University’s Lombardi Comprehensive Cancer Center scientists and colleagues provides a much-needed assessment of how these products could lead to potential harmful consequences if used by young people.
A video and story with insights from three mental health professionals with expertise in firearm injury prevention
Researchers at Washington University School of Medicine in St. Louis found that pregnant people who took ADHD medications while also being treated for opioid use disorder continued to take medication to address their opioid use disorder about two months longer than patients who stopped taking ADHD medications.
UC San Diego School of Medicine part of $50M initiative to use predictive AI to help fight opioid abuse.
A clinical trial on a two-drug therapy for methamphetamine use disorder reduced use of the highly addictive drug for up to 12 weeks after initiation of treatment. To date there is no FDA-approved medication for it.
Restricting menthol flavor in cigarettes while making nicotine replacement therapy, such as a skin patch that can help ease withdrawal, more available and affordable has the potential to reduce socioeconomic disparities in tobacco use.
Nearly one in six patients in primary care reported cannabis use, with 35% of those using at levels indicating moderate- to high-risk use disorder. The findings indicate the need for routine cannabis use screening. Currently few healthcare systems offer this screening in primary care settings.
Physical and sexual abuse, having parents who misuse substances, and witnessing violent crime are tragic events that don’t remain locked in a single point in time. Rather, they are termed adverse childhood experiences (ACEs) and 64 percent of American adults who participated in a recent survey reported experiencing at least one ACE prior to turning 18 years old.
New research from the University of South Australia (UniSA) and Curtin University finds that up to 36% of young people leaving foster homes in Australia wind up homeless – compared to less than 10% of the general youth population.
A new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and recurrence of alcohol abuse or dependence.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
